Glaxosmithkline Plc (GSK)

$ 38.07
   
  • Change Today:
    $0.00
  • 52 Week High: $44.26
  • 52 Week Low: $32.08
  • Currency: US Dollars
  • Shares Issued: 465.72m
  • Volume: 12,223
  • Market Cap: $17,730m
  • RiskGrade: 119
  • Beta: 0.23

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
Brands: Lucozade, Horlicks, Ribena, Paxil, Seroxat

Key Personnel

CEO: Emma Walmsley
Chief Finance Officer: Julie Brown
Independent Non-Executive Director: Elizabeth (Liz) McKee Anderson
Independent Non-Executive Director: Anne Beal
Independent Non-Executive Director: Harry (Hal) C. Dietz
Independent Non-Executive Director: Vishal Sikka
Non-Executive Chairman: Jonathan Symonds
Senior Independent Non-Executive Director: Charles Bancroft
Non-Executive Dir: Jeannie Lee , Hal Barron , Gavin Screaton, Wendy Becker

Contact Details

Address: 79 New Oxford Street, London, United Kingdom, WC1A 1DG
Phone: +44 (0)20 8047 5000
Website: http://www.gsk.com

Listings

Overseas Listings: BATSLON:GSKL, LSE:GSK
ISIN: US37733W2044

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency US Dollars
Share Price $ 38.07
Change Today $ 0.00
% Change 0.00 %
52 Week High $44.26
52 Week Low $32.08
Volume 12,223
Shares Issued 465.72m
Market Cap $17,730m
Beta 0.23
RiskGrade 119

Trades for --2025

Time Volume / Share Price
0 @ $0.00

GSK Key Personnel

CEO Emma Walmsley

Top of Page